Two Sigma Advisers’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $653K | Buy |
|
|||||
|
2025
Q1 | $590K | Buy |
|
|||||
|
2024
Q4 | $722K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $294K | Sell |
|
|||||
|
2024
Q1 | $957K | Sell |
|
|||||
|
2023
Q4 | $1.13M | Buy |
|
|||||
|
2023
Q3 | $506K | Sell |
|
|||||
|
2023
Q2 | $1.31M | Sell |
|
|||||
|
2023
Q1 | $1.89M | Sell |
|
|||||
|
2022
Q4 | $3.75M | Buy |
|
|||||
|
2022
Q3 | $5.32M | Buy |
|
|||||
|
2022
Q2 | $2.42M | Buy |
|
|||||
|
2022
Q1 | $3.29M | Sell |
|
|||||
|
2021
Q4 | $5.82M | Sell |
|
|||||
|
2021
Q3 | $8.67M | Sell |
|
|||||
|
2021
Q2 | $12.2M | Sell |
|
|||||
|
2021
Q1 | $17.6M | Sell |
|
|||||
|
2020
Q4 | $22.1M | Buy |
|
|||||
|
2020
Q3 | $12.9M | Buy |
|
|||||
|
2020
Q2 | $9.88M | Buy |
|
|||||
|
2020
Q1 | $1.92M | Buy |
|
|||||
|
2019
Q4 | $1.42M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $2.13M | Sell |
|
|||||
|
2019
Q1 | $2.14M | Buy |
|
|||||
|
2018
Q4 | $2.33M | Buy |
|
|||||
|
2018
Q3 | $1.75M | Sell |
|
|||||
|
2018
Q2 | $1.95M | Sell |
|
|||||
|
2018
Q1 | $4.67M | Sell |
|
|||||
|
2017
Q4 | $4.76M | Buy |
|
|||||
|
2017
Q3 | $432K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $36K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $212K | Buy |
|
|||||
|
2016
Q1 | $97K | Buy |
|
|||||
|
2015
Q4 | $93K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $249K | Buy |
|
|||||
|
2014
Q3 | $173K | Sell |
|
|||||
|
2014
Q2 | $376K | Buy |
|